3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced ...Middle East

HONG KONG, Aug. 24, 2023 /PRNewswire/ -- Chinese leading biopharmaceutical company 3SBio (01530.HK) today released its 2023 interim results. Revenue in the first half of 2023 reached approximately RMB3,783.8 million, up 22.3% on a yearly basis. Gross profit was approximately RMB3,201.6...

Hence then, the article about 3sbio announces 2023 interim results with revenue growing over 20 year on year and pipeline value constantly enhanced was published today ( Friday 25/08/2023 - 05:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( 3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced )

Also on site :

• 1990 Tearjerker Voted ‘Best Country Song’ of All Time
• TJ Maxx Is Selling a Lookalike of a Popular Anthropologie Doormat Over 3x the Price
• The Cozy One-Pot Dinner I’m Making on Repeat All Winter Long